Cargando…
The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175382/ https://www.ncbi.nlm.nih.gov/pubmed/34083505 http://dx.doi.org/10.1038/s41392-021-00635-y |
| _version_ | 1783703044822663168 |
|---|---|
| author | Yang, Chang Lou, Ge Jin, Wei-Lin |
| author_facet | Yang, Chang Lou, Ge Jin, Wei-Lin |
| author_sort | Yang, Chang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8175382 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81753822021-06-07 The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies Yang, Chang Lou, Ge Jin, Wei-Lin Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2021-06-03 /pmc/articles/PMC8175382/ /pubmed/34083505 http://dx.doi.org/10.1038/s41392-021-00635-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Research Highlight Yang, Chang Lou, Ge Jin, Wei-Lin The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies |
| title | The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies |
| title_full | The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies |
| title_fullStr | The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies |
| title_full_unstemmed | The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies |
| title_short | The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies |
| title_sort | arsenal of tp53 mutants therapies: neoantigens and bispecific antibodies |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175382/ https://www.ncbi.nlm.nih.gov/pubmed/34083505 http://dx.doi.org/10.1038/s41392-021-00635-y |
| work_keys_str_mv | AT yangchang thearsenaloftp53mutantstherapiesneoantigensandbispecificantibodies AT louge thearsenaloftp53mutantstherapiesneoantigensandbispecificantibodies AT jinweilin thearsenaloftp53mutantstherapiesneoantigensandbispecificantibodies AT yangchang arsenaloftp53mutantstherapiesneoantigensandbispecificantibodies AT louge arsenaloftp53mutantstherapiesneoantigensandbispecificantibodies AT jinweilin arsenaloftp53mutantstherapiesneoantigensandbispecificantibodies |